# T2 Biosystems, Inc.

T2 Biosystems, Inc. is a company headquartered in Lexington, MA, United States.

## Company overview

- **Legal name:** T2 Biosystems, Inc.
- **Classification:** Company
- **Industry (SIC):** 3841 — Surgical & Medical Instruments & Apparatus
- **Headquarters:** Lexington, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001492674

## About

T2 Biosystems, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001492674, and its reported industry is Surgical & Medical Instruments & Apparatus. In 10-K filed on 2024-04-01, it reported annual revenue of USD 7,193,000; net income of USD -50,077,000; total assets of USD 34,797,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $7.2M (USD 7,193,000)
- **Net income:** -$50.1M (USD -50,077,000)
- **Total assets:** $34.8M (USD 34,797,000)
- **Cash and equivalents:** $15.7M (USD 15,689,000)
- **Operating cash flow:** -$48.1M (USD -48,136,000)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $22.3M (USD 22,305,000)
- **Net income:** -$62.0M (USD -62,003,000)
- **Total assets:** $34.3M (USD 34,327,000)
- **Cash and equivalents:** $10.3M (USD 10,329,000)
- **Operating cash flow:** -$50.6M (USD -50,629,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $28.1M (USD 28,058,000)
- **Net income:** -$49.2M (USD -49,241,000)
- **Total assets:** $60.5M (USD 60,539,000)
- **Cash and equivalents:** $22.2M (USD 22,245,000)
- **Operating cash flow:** -$38.9M (USD -38,874,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $18.1M (USD 18,130,000)
- **Net income:** -$46.8M (USD -46,798,000)
- **Total assets:** $79.1M (USD 79,078,000)
- **Cash and equivalents:** $16.8M (USD 16,793,000)
- **Operating cash flow:** -$43.2M (USD -43,215,000)

## Recent SEC filings

- Form 8-K — filed 2025-04-07 — period 2025-03-18 — 8-K
- Form 8-K — filed 2025-02-20 — period 2025-02-20 — 8-K
- Form 8-K — filed 2025-02-14 — period 2025-02-13 — 8-K
- Form 8-K — filed 2025-02-11 — period 2025-02-10 — 8-K
- Form DEF 14A — filed 2025-01-21 — period 2025-03-03 — DEF 14A
- Form 8-K — filed 2025-01-17 — period 2025-01-16 — 8-K
- Form 8-K — filed 2025-01-07 — period 2025-01-07 — 8-K
- Form 8-K — filed 2025-01-03 — period 2024-12-30 — 8-K
- Form 8-K — filed 2024-12-13 — period 2024-12-12 — 8-K
- Form 8-K — filed 2024-12-09 — period 2024-12-09 — 8-K
- Form DEF 14A — filed 2024-11-20 — period 2024-12-30 — DEF 14A
- Form 8-K — filed 2024-11-15 — period 2024-11-14 — 8-K

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/t2-biosystems-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology